![](https://monteverdelaw.com/wp-content/uploads/case-logo/forma-therapeutics-holdings-inc.png)
Forma Therapeutics Holdings, Inc. (FMTX), relating to its proposed acquisition by Novo Nordisk A/S. Under the terms of the tender offer, FMTX shareholders are expected to receive $20.00 in cash per share they own.
Forma Therapeutics Holdings, Inc. (FMTX), relating to its proposed acquisition by Novo Nordisk A/S. Under the terms of the tender offer, FMTX shareholders are expected to receive $20.00 in cash per share they own.